Aishwarya Sitaram
Investor Relations, Dr. Reddy's Laboratories
Replay available
Dr. Reddy's Laboratories Ltd (NYSE: RDY) Q2 2026 earnings conference call, held 2025-10-24. Replay captured from the company's public earnings webcast.

Investor Relations, Dr. Reddy's Laboratories
Head, Investor Relations, Dr. Reddy's Laboratories
Chief Executive Officer
Analyst, Bank of America
Analyst, HSBC
Analyst, Illala Capital
Analyst, Nomura
Analyst, Fidelity International
Analyst, Bakwari Capital
Analyst, Motilal Oswal Financial Services
Analyst, Citi
Analyst, Evendus Park
Analyst, Central Capital
Good day and welcome to Q2 fiscal year 2020. I'm Aishwarya Sitaram and I'm part of the Dr. Eddy's Investor Relations team. I'd like to indicate that all participants will be in the listen-only mode during the opening remarks and there will be an opportunity for you to ask questions thereafter. Should you need any technical assistance during the call, please use the chat function in your Zoom application. Please note that the chat will not be monitored for any questions to the management. I now hand over the conference to Richa Parimal. Thank you. Thanks, Aishwarya. Good morning, good evening, and a warm welcome to all. We hope you had a joyful and safe Diwali celebration with your loved ones. Thank you for joining us for Dr. Reddy's Laboratories Q2 FY26 Earnings Conference Call. We truly value your time and participation. Joining us today are members of the leadership team, Mr. Ivez Israeli, CEO, Mr. Mvn, our CFO, and the investor relations team. Earlier today, we released our quarterly financial results. These are now available on your website for your reference. We will begin today's session with Mvn providing an overview of our financial performance for the quarter. Following that, Erase will share his insights on key business highlights and our strategic outlook. We will then open the floor for questions. Before we proceed, please note that this call is the proprietary material of Dr. Reddy's Laboratories and may not be rebroadcasted or quoted in any media or public forum without prior written consent from the company. This session is being recorded and both the audio and the transcript will be made available on our website shortly. All commentary and analysis during this call are based on our IFRS consolidated financial statements. Please note that certain non-G...